Benefits and risks of the sanofi-pasteur dengue vaccine: Modeling optimal deployment

Science

Volumn 353, Issue 6303, 2016, Pages 1033-1036

  Ferguson, Neil M ^a   Rodríguez Barraquer, Isabel ^b   Dorigatti, Ilaria ^a   Mier Y Teran Romero, Luis ^b   Laydon, Daniel J ^a   Cummings, Derek A T ^b,c  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DENGUE VACCINE; DENGVAXIA; LIVE VACCINE; RECOMBINANT VACCINE; UNCLASSIFIED DRUG;

DISEASE TRANSMISSION; HEALTH POLICY; HEALTH RISK; IMMUNITY; MODELING; POLICY MAKING; VACCINATION; VACCINE; VIRAL DISEASE;

ARTICLE; DENGUE; DENGUE VIRUS; DRUG EFFICACY; HOSPITALIZATION; HUMAN; INCIDENCE; INFECTION PREVENTION; MATHEMATICAL MODEL; MULTICENTER STUDY (TOPIC); NONHUMAN; PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SECONDARY INFECTION; SEROPREVALENCE; TREATMENT OUTCOME; VACCINATION; VIRUS IMMUNITY; VIRUS TRANSMISSION; ADOLESCENT; CHILD; CLINICAL TRIAL (TOPIC); IMMUNOLOGY; PRESCHOOL CHILD; RISK ASSESSMENT; THEORETICAL MODEL; TRANSMISSION; VACCINE IMMUNOGENICITY;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS AS TOPIC; DENGUE; DENGUE VACCINES; DENGUE VIRUS; HOSPITALIZATION; HUMANS; IMMUNOGENICITY, VACCINE; MODELS, THEORETICAL; RISK ASSESSMENT; VACCINATION; VACCINES, ATTENUATED;

EID: 84984863679     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.aaf9590     Document Type: Article

References (35)

1. J. R. Stephenson, Bull. World Health Organ. 83, 308-314 (2005).
2. R. Edelman, J. Hombach, Vaccine 26, 4113-4119 (2008).
3. B. R. Murphy, S. S. Whitehead, Annu. Rev. Immunol. 29, 587-619 (2011).
4. S. B. Halstead, Prog. Allergy 31, 301-364 (1982).
5. D. S. Burke, A. Nisalak, D. E. Johnson, R. M. Scott, Am. J. Trop. Med. Hyg. 38, 172-180 (1988).
6. M. R. Capeding et al., Lancet 384, 1358-1365 (2014).
7. L. Villar et al., N. Engl. J. Med. 372, 113-123 (2015).
8. A. Sabchareon et al., Lancet 380, 1559-1567 (2012).
9. S. R. Hadinegoro et al., N. Engl. J. Med. 373, 1195-1206 (2015).
10. L. Á. Villar et al., Pediatr. Infect. Dis. J. 32, 1102-1109 (2013).
11. G. H. Dayan et al., Am. J. Trop. Med. Hyg. 89, 1058-1065 (2013).
12. Y. Sin Leo etal., Hum. Vaccin. Immunother. 8, 1259-1271 (2012).
13. C. F. Lanata et al., Vaccine 30, 5935-5941 (2012).
14. R. Z. Capeding et al., Vaccine 29, 3863-3872 (2011).
15. D. Morrison et al., J. Infect. Dis. 201, 370-377 (2010).
16. I. Dorigatti et al., Vaccine 33, 3746-3751 (2015).
17. M. R. Capeding T. M. Laot M. Boaz T. A. Wartel D. Crevat Trials Vaccinol. 4, 19-23 (2015).
18. B. Guy, N. Jackson, Nat. Rev. Microbiol. 14, 45-54 (2016).
19. I. Rodríguez-Barraquer, L. Mier-y-Teran-Romero, D. S. Burke, D. A. T. Cummings, PLOS Negl. Trop. Dis. 7, e2126 (2013).
20. T. J. Kochel et al J Infect Dis 191 1000-1004 (2005)
21. A. B. Sabin, Am. J. Trop. Med. Hyg. 1, 30-50 (1952).
22. A. B. Sabin, Bacteriol. Rev. 14, 225-232 (1950).
23. S. Olkowski et al., J. Infect. Dis. 208, 1026-1033 (2013).
24. P. S. Wikramaratna, C. P. Simmons, S. Gupta, M. Recker, PLOS ONE 5, e12347 (2010).
25. A. Nisalak et al., Am. J. Trop. Med. Hyg. 68, 191-202 (2003).
26. Strategic Advisory Group of Experts on Immunization, "Summary of the April 2016 meeting of the Strategic Advisory Group of Experts on Immunization (SAGE)", Geneva, Switzerland, 12 to 14 April 2016 (SAGE, WHO, Geneva, 2016); http://www.who.int/immunization/sage/meetings/2016/april/SAGE-April-2016-Meeting-Web-summary.pdf?ua=1.
27. H. Q. McLean, A. P. Fiebelkorn, J. L. Temte, G. S. Wallace, MMWR Recomm. Rep. 62(RR-04), 1-34 (2013).
28. Centers for Disease Control and Prevention, Morb. Mortal. Wkly. Rep. 37, 341-346 (1988)
29. L. Coudeville, N. Baurin, E. Vergu, Vaccine 10.1016/j.vaccine.2015.11.023 (2015).
30. I. Rodríguez-Barraquer, L. Mier-y-Teran-Romero, N. Ferguson, D. S. Burke, D. A. T. Cummings, Lancet 385, 1726 (2015).
31. T. J. Hladish et al., PLOS Negl. Trop. Dis. 10, e0004661 (2016).
32. N. M. Ferguson et al., Sci. Transl. Med. 7, 279ra37 (2015).
33. C. Sirivichayakul et al., J. Infect. Dis. 213, 1562-1572 (2016).
34. B. D. Kirkpatrick et al., J. Infect. Dis. 212, 702-710 (2015).
35. M. A. Penny et al., Lancet 387, 367-375 (2016).